Improving the Remission Quality in Acute Myelogenous Leukemia (AML) by Increasing Cytoreduction During Induction Therapy
暂无分享，去创建一个
T. Ahmed | A. Mittelman | L. Helson | Z. Arlin | P. Baskind | H. Chun | C. Puccio | P. Cook
[1] L. Finger,et al. Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia. , 1991, Leukemia.
[2] Abildgaard Cf. Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group. , 1991 .
[3] H. Preisler,et al. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. , 1987, Blood.
[4] C. Begg,et al. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia. , 1987, Cancer treatment reports.
[5] C. Bloomfield,et al. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. , 1981, Blood.
[6] A. Raza,et al. [Treatment of acute nonlymphocytic leukemia]. , 1991, Gematologiia i transfuziologiia.